V. F. Kirichuk, “Results and Perspectives of Experimental Validation of Application of Terahertz Electromagnetic Waves with Frequencies Equal to Frequencies of Molecular Absorption and Emission Spectra (MAES) of Various Cell Metabolites in Clinical Practice,” Millimetrovye Volny v Biologii i Meditsyne (Millimeter Waves in Biology and Medicine), No. 1, 2012, pp. 5-24.

has been cited by the following article:

• TITLE: Correction of Disorders in Tissue Perfusion, Blood Coagulation and Fibrinolysis with Orbita Apparatus on Terahertz Waves of Cell Metabolites

  AUTHORS: Vaycheslav Kirichuk, Alexander Tsymbal, Alexey Ivanov, Evgeniy Andronov, Tatyana Kiriyazi, Svetlana Parshina, Natalia Babichenko, Liliana Tokaeva

  KEYWORDS: Orbita Apparatus; Terahertz Waves; Nitrogen Oxide; Atmospheric Oxygen; Stress; Peripheral Perfusion; Coagulation; Fibrinolytic Disorders

  JOURNAL NAME: Engineering, Vol.5 No.2, February 7, 2013

  ABSTRACT: This article contains information on principle of operation, technical parameters and possible application of Orbita apparatus for hemodynamic, fibrinolytic and peripheral perfusion disorders treatment. A single exposure to terahertz waves emitted by Orbita apparatus, corresponding to frequencies of molecular absorption and emission spectra of atmospheric oxygen (129.0 GHz), completely cures coagulant and fibrinolytic disorders of animals with acute immobilization stress. A course of treatment with electromagnetic waves corresponding to frequencies of molecular absorption and emission spectra of nitrogen oxide (150.176 - 150.664) leads to normalization of disrupted peripheral tissue perfusion parameters of animal undergoing treatment and stimulates basal and induced output of nitrogen oxide. This leads to decrease in peripheral vascular resistance to microcirculation and increase in blood flow to microvasculature. Experimental data provided in this article serves as a proof of viability of Orbita apparatus for treatment of coagulant, fibrinolytic and tissue perfusion disorders.